SLC7A11/GPX4-dependent resistance to ferroptosis induction in acute myeloid leukemia cells: molecular markers and therapeutic prospects

The review presents an analysis of current literature data on the role of iron-dependent regulated cell death (ferroptosis) in the pathogenesis of acute myeloid leukemia (AML). The molecular mechanisms of SLC7A11/GPX4-dependent resistance of leukemic cells to ferroptosis induction are discussed, including transcriptional regulation of anti-ferroptotic genes by NRF2, p53, ATF4 factors, as well as epigenetic modifications. Special attention is paid to the role of leukemic stem cells in maintaining resistance through activation of alternative defense pathways (FSP1–CoQ10, DHODH) and regulation of iron homeostasis. Experimental data obtained on AML cell lines (HL-60, KG-1, MOLM-13, MV4-11, THP-1) and therapeutic strategies for pharmacological blockade of the SLC7A11–GSH–GPX4 axis using ferroptosis inducers (erastin, RSL3, ML162) are analyzed. The prospects of combination therapy with targeted drugs, hypomethylating agents, and lipid metabolism modulators are discussed. Molecular markers (SLC7A11, GPX4, ACSL4, FSP1, NRF2, lipid peroxidation level) for patient stratification and personalization of treatment for resistant forms of AML are highlighted.

1. Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN / H. Döhner [et al.] // Blood. – 2022. – Vol. 140, No. 12. – P. 1345–1377.

2. Pollyea, D. A. Therapeutic targeting of acute myeloid leukemia stem cells / D. A. Pollyea, C. T. Jordan // Blood. – 2017. – Vol. 129, No. 12. – P. 1627–1635.

3. Ferroptosis: an iron-dependent form of nonapoptotic cell death / S. J. Dixon [et al.] // Cell. – 2012. – Vol. 149, No. 5. – P. 1060–1072.

4. Gan, B. Mitochondrial regulation of ferroptosis / B. Gan // Journal of Cell Biology. – 2021. – Vol. 220, No. 9. – Article e202105043.

5. Ursini, F. Lipid peroxidation and ferroptosis: the role of GSH and GPx4 / F. Ursini, M. Maiorino // Free Radical Biology and Medicine. – 2020. – Vol. 152. – P. 175–185.

6. Ferroptosis in infection, inflammation, and immunity / X. Chen [et al.] // Journal of Experimental Medicine. – 2021. – Vol. 218, No. 6. – Article e20210518.

7. Regulating ferroptosis in leukemic stem cells / Y. Ma [et al.] // Stem Cell Reviews and Reports. – 2025. – Vol. 21. – P. 1–28.

8. Targeted exosome-encapsulated erastin induced ferroptosis in triple negative breast cancer cells / M. Yu [et al.] // Cancer Science. – 2019. – Vol. 110, No. 10. – P. 3173–3182.

9. Koppula, P. Cystine transporter SLC7A11/xCT in cancer: ferroptosis, nutrient dependency, and cancer therapy / P. Koppula, L. Zhuang, B. Gan // Protein & Cell. – 2021. – Vol. 12, No. 8. – P. 599–620.

10. Lu, S. C. Glutathione synthesis / S. C. Lu // Biochimica et Biophysica Acta. – 2013. – Vol. 1830, No. 5. – P. 3143–3153.

11. HMGB1 regulates erastin-induced ferroptosis through the Ras/JNK/p38 signaling pathway in HL-60/ NRASQ61L cells / P. Ye [et al.] // Oncology Letters. – 2019. – Vol. 18, No. 3. – P. 2533–2539.

12. Ferroptosis: process and function / Y. Xie [et al.] // Cell Death and Differentiation. – 2016. – Vol. 23, No. 3. – P. 369–379.

13. Erastin-induced ferroptosis in HL-60 cells / M. Yu [et al.] // Hematology. – 2019. – Vol. 24, No. 1. – P. 517–523.

14. Selenium utilization by GPX4 is required to prevent hydroperoxide-induced ferroptosis / I. Ingold [et al.] // Cell. – 2018. – Vol. 172, No. 3. – P. 409–422.

15. Ursini, F. The role of selenium peroxidases in the protection against oxidative damage of membranes / F. Ursini, M. Maiorino // Chemistry and Physics of Lipids. – 1988. – Vol. 44, No. 2–4. – P. 255–276.

16. Drug-tolerant persister cancer cells are vulnerable to GPX4 inhibition / M. J. Hangauer [et al.] // Nature. – 2017. – Vol. 551, No. 7679. – P. 247–250.

17. Recent progress in ferroptosis inducers for cancer therapy / C. Liang [et al.] // Advanced Materials. – 2019. – Vol. 31, No. 51. – Article e1904197.

18. Matrine enhances RSL3-induced ferroptosis at non-toxic doses in acute myeloid leukemia cells with MLL rearrangement / Y. Li [et al.] // Journal of Translational Medicine. – 2022. – Vol. 20, No. 1. – Article 540.

19. Rojo de la Vega, M. NRF2 and the hallmarks of cancer / M. Rojo de la Vega, E. Chapman, D. D. Zhang // Cancer Cell. – 2018. – Vol. 34, No. 1. – P. 21–43.

20. BAP1 links metabolic regulation of ferroptosis to tumour suppression / Y. Zhang [et al.] // Nature Cell Biology. – 2018. – Vol. 20, No. 10. – P. 1181–1192.

21. Combinations of HDAC inhibitor and PPAR agonist induce ferroptosis of leukemic stem cell-like cells in acute myeloid leukemia / H. Zhou [et al.] // Clinical Cancer Research. – 2024. – Vol. 30, No. 23. – P. 5430–5444.

22. Targeting BMAL1 reverses drug resistance of acute myeloid leukemia cells and promotes ferroptosis through HMGB1-GPX4 signaling pathway / H. Zheng [et al.] // Journal of Cancer Research and Clinical Oncology. – 2024. – Vol. 150, No. 5. – Article 231.

23. NSUN2-mediated cytosine-5 methylation of FSP1 protects acute myeloid leukemia cells from ferroptosis / L. Chen [et al.] // Cell Death & Disease. – 2025. – Vol. 16. – Article 372.

24. Role of ferroptosis in AML pathophysiology and therapeutic strategies / G. Favale [et al.] // Ferroptosis: From Bench to Bedside. – London : IntechOpen, 2025. – DOI: 10.5772/intechopen.1011347. – URL: https://www.intechopen.com/chapters/1210363 (date of access: 08.07.2026).

25. Susceptibility of acute myeloid leukemia cells to ferroptosis and evasion strategies / K. Liu [et al.] // Frontiers in Oncology. – 2023. – Vol. 13. – Article 1250897.

26. Lei, G. Targeting ferroptosis as a vulnerability in cancer / G. Lei, L. Zhuang, B. Gan // Nature Reviews Cancer. – 2022. – Vol. 22, No. 7. – P. 381–396.

27. Jiang, X. Ferroptosis: mechanisms, biology and role in disease / X. Jiang, B. R. Stockwell, M. Conrad // Nature Reviews Molecular Cell Biology. – 2021. – Vol. 22, No. 4. – P. 266–282.

28. ACSL4 dictates ferroptosis sensitivity by shaping cellular lipid composition / S. Doll [et al.] // Nature Chemical Biology. – 2017. – Vol. 13, No. 1. – P. 91–98.

29. The CoQ oxidoreductase FSP1 acts parallel to GPX4 to inhibit ferroptosis / K. Bersuker [et al.] // Nature. – 2019. – Vol. 575, No. 7784. – P. 688–692.

30. DHODH-mediated ferroptosis defence is a targetable vulnerability in cancer / F. Müller [et al.] // Nature. – 2023. – Vol. 593, No. 7860. – P. 586–590.